Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choosing Neoadjuvant Chemotherapy Versus Hormonal Therapy for Breast Cancer Based on Gene Expression Profile

NCT01293032 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01293032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01293032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choosing Neoadjuvant Chemotherapy Versus Hormonal Therapy for Breast Cancer Based on Gene Expression Profile
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
March 31, 2016
Enrollment
59 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, lobular breast carcinoma in situ, stage ii breast cancer, stage iia breast cancer, stage iib breast cancer, stage iiia breast cancer, stage iiib breast cancer